RNXT
RENOVORX (RNXT)
NASDAQ
$0.93+$0.02 (+2.58%)
Price as of Jun 03, 2026 7:16 PM EDT
  • $41.0M
    Market Cap
  • -33.54%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
1.1M
+2,511.63%
43,000
N/A
N/A
N/A
0
+100.00%
Cost of Revenue
327,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
796,000
+1,751.16%
43,000
N/A
0
N/A
0
+100.00%
Sales and Marketing Expense
7.0M
+41.08%
5.0M
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-6.3M
+4.05%
-6.0M
+6.32%
-5.7M
+31.76%
-4.3M
+41.53%
Depreciation and Amortization Expense
2,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
13.3M
+20.82%
11.0M
-3.36%
11.4M
+14.53%
9.9M
+75.45%
Operating Profit
-12.5M
+14.04%
-11.0M
-3.74%
-11.4M
+14.53%
-9.9M
+75.45%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
0
+100.00%
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
+100.00%
Total Nonoperating Income and Expense
1.3M
-37.76%
2.2M
+85.22%
1.2M
+1,808.20%
61,000
+109.34%
Income before Taxes
-12.5M
+14.04%
-11.0M
-3.74%
-11.4M
+14.53%
-9.9M
+75.45%
Income Taxes
2,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-11.2M
+26.71%
-8.8M
-13.86%
-10.2M
+3.47%
-9.9M
+56.37%
Net Income from Continuing Operations Applicable to Common
0
N/A
N/A
N/A
-10.2M
+3.47%
-9.9M
+56.37%
Basic EPS and Net Income
-0.32
-20.00%
-0.40
-59.60%
-0.99
-9.17%
-1.09
-9.92%
Diluted EPS and Net Income
-0.32
-20.00%
-0.40
-59.60%
-0.99
-9.17%
-1.09
-9.92%
Basic Weighted Average Shares
35.3M
+58.65%
22.3M
+116.42%
10.3M
+13.69%
9.1M
+73.50%
Diluted Weighted Average Shares
35.3M
+58.65%
22.3M
+116.42%
10.3M
+13.69%
9.1M
+73.50%
Balance Sheet
Cash and Cash Equivalents
7.0M
-1.82%
7.2M
+509.89%
1.2M
-73.29%
4.4M
-71.10%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
2.0M
N/A
Cash and Cash Equivalents and Short-Term Investments
7.0M
-1.82%
7.2M
+509.89%
1.2M
-81.79%
6.4M
-57.61%
Total Current Assets
7.9M
+0.83%
7.8M
+473.48%
1.4M
-81.21%
7.3M
-55.38%
Accumulated Depreciation
2,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
12,000
0.00%
12,000
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
12,000
0.00%
12,000
-88.12%
101,000
N/A
N/A
N/A
Total Assets
8.1M
-0.28%
8.1M
+453.75%
1.5M
-79.82%
7.3M
-55.39%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.0M
+2.78%
1.9M
+62.47%
1.2M
+6.62%
1.1M
+17.48%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
5.3M
0.00%
Total Long-Term Liabilities
107,000
-49.53%
212,000
N/A
N/A
N/A
N/A
N/A
Total Liabilities
2.7M
-26.57%
3.6M
-18.50%
4.5M
+305.26%
1.1M
+17.48%
Retained Earnings
-61.4M
+22.24%
-50.2M
+21.29%
-41.4M
+32.82%
-31.2M
+46.46%
Total Stockholders Equity
5.4M
N/A
N/A
N/A
-3.0M
-148.68%
6.2M
-59.85%
Total Shares Outstanding
36.6M
+52.34%
24.0M
+124.76%
10.7M
+17.54%
9.1M
+1.83%
Cash Flow
Cash from Operating Activities
-11.0M
+20.25%
-9.1M
-11.05%
-10.3M
+16.42%
-8.8M
+48.94%
Capital Expenditures
2,000
-83.33%
12,000
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-2,000
-83.33%
-12,000
-100.59%
2.0M
+200.00%
-2.0M
+13,446.67%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
10.8M
-28.26%
15.1M
+201.88%
5.0M
+11,823.81%
42,000
-99.78%
Financials Ratio
Gross Margin
70.88%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-1,113.98%
-95.63%
-25,511.63%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-137.77%
-25.10%
-183.93%
-21.53%
-234.38%
+179.11%
-83.98%
N/A
Return on Equity
N/A
N/A
N/A
N/A
-646.98%
+603.70%
-91.94%
N/A
Revenue Growth
2,511.63%
N/A
N/A
N/A
N/A
N/A
100.00%
N/A
Current Ratio
4.02
-1.89%
4.10
+252.98%
1.16
-82.38%
6.59
N/A
Cash Ratio
3.58
-4.47%
3.75
+275.39%
1.00
-74.95%
3.98
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow